title: Combination therapy of infliximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis.
authors.forename: Tomomi
authors.initials: T
authors.lastname: Fujisawa
authors.forename: Chie
authors.initials: C
authors.lastname: Moriya
authors.forename: Yoshinao
authors.initials: Y
authors.lastname: Shibuya
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kanoh
authors.forename: Mariko
authors.initials: M
authors.lastname: Seishima
mesh_terms: D000327:Adsorption; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006098:Granulocytes / Q000276:immunology*; D006801:Humans; D000069285:Infliximab; D007937:Leukapheresis / Q000379:methods*; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D012074:Remission Induction; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab